Bitter Pills:Medicines & The Third World Poor | Page 111

Nil.
Product licence number

Further Information

Protect from light.

0065/5043

Bottles of 100 tablets

POM.
Peckaae quantities

Legal category

Pharmaceutical procautiona

The possibility of menstrual disturbances exists.
probably resulting from an inhibition of the secretion
of gonadotrophins from the pituitary and/or from the
occurrence of a progestational effect. In such cases the
treatment should be discontinued or the dosage decreased.

development of 'igpatjr '^"TOWff cannot at present be V
excluded and this should be considered when the use!
of this product is proposed, especially in young people!
uttering from lite-threateninadisordi
IJI Ul I1IHI UVslUnction. hypertension or epilepsy should be observed carefully, since
anabolic steroids may cause fluid retention.
Skeletal maturation should be followed carefully
when treating young people, since anabolic steroids in
high dosages may accelerate this process.
Caution should be observed in young women whose
cycles are not yet stabilised.
In diabetics, the need tor insulin or other anti-diabetic drugs may be reduced.
When administered in the recommended dosages
and for short periods of time (up to four weeks) sideeffects may occur very rarely. Occasionally* after high
dosages, some liver function tests show abnormal
values. These deviations, however, are transient and
completely
reversible
after
discontinuation
of
treatment. In some cases, particularly those treated with
high dosages, nausea andJSome water retention m a j j

lIurpflUrlBllhelivalhiivt. been reported occasionally
in patients
suojecieo
(o prolonged
treatm
ih C
p
j
pg
m
i
b
l
i
t
'
m-alkylatedandrooenic-anabolicsterc

Treatment should be discontinued if cholestatic
jaundice appears or liver function tests become

Presentation
Ethyloestrenol Tablets Round, fist
white tablets, diameter 9mm, code-marked SB3' on
one side, with 'Orgtnon' and Hat on the reverse side
Active ingredient: Ethyloestrenol B P 2 m g per tablet.
Uee* Ethvtoestrenol i t an anabolic agent, the nitrogen and calcium retaining effects of which are fully
effective when it ia administered orally.
Dosage " i f —«»flfplatration Adult*- ^-9 tablets
orally dailvlHot recommended lew children^
Contra-Indications, warning*. e t c C o n t r a -1 n dicated in pregnancy, proststic carcinoma, breast carcinoma in the male and in severe disturbances of liver
function.

ORABOLIN *

Conflicting information on prescribing for children. Left, therapeutic information, Bangladesh; right, entry from data
sheet for British doctors.

adrenal*
jTaspberry flavoured liquid administered in drops is especiaMy^
meant for younger children and infants.
»——
—
Indication :
In adults- Convalescence, weight loss, debility, osteoporosis,
stow-healing fractures, during corticoid therapy, as an adjuvant
after acute and chronic diseases.
In Children:- Retarded growth, lack of appetite and insufficient
weight, nutritional discirdars. failure to thrive and after infectious
•diseases.
Dosage :
Adults : 2 tablets daily
Children : According to body weight
Drops per day
Weight in Kg.
6 drops
Less than 10 kg.
1 drop/kg.
10-30 Kg.
30 drops.
more than 30 kg.
Packing :
Bottles of 20 tablets.
Oropper-bottles of 5 ml.

Clinical Effects :
Ethylestr.nol. t h . activ. principl. of ORABOLIN. I . • P<>«*™
anabolic agant which I . fully effactiva whan orally • * ' ' " " « • " * •
Extensive tests have shown that ethylestrenol hat an • " • J 0 " c / a n f roganic ratio almost 20 times than that of ™ " h V ' " s t ° s f ' " ? n t : J "
practice the small daily dose required. 0.05 mg. per K 9 . body
weight, ensures that the only clinical affect is anabolism.
ORABOLIN stimulates the appetite, promotes weight gain and in
elderly debilitated patients produceja marked psychological improvement. Metabolic balance studies have shown that both
nitrogen and calcium are retained during treatment, and that a
negative nitrogen balance during corticosteroid therapy can be
reversed. ORABOLIN is exceptionally wall tolerated. (tjajtsefnq"
"(and isffree from harmful effects on liver} and

Composition'
Tablets containing 2 mg. Ethylestrenol.
Drops containing 2 mg. Ethvlastranol pai ml. aqueous tolution.

ORABOLIN
Tablet! and Drops